Susquehanna International Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6M | Buy |
|
|||||
|
2025
Q1 | $3.22M | Buy |
|
|||||
|
2024
Q4 | $954K | Buy |
|
|||||
|
2024
Q3 | $597K | Sell |
|
|||||
|
2024
Q2 | $539K | Sell |
|
|||||
|
2024
Q1 | $1.78M | Buy |
|
|||||
|
2023
Q4 | $480K | Buy |
|
|||||
|
2023
Q3 | $203K | Sell |
|
|||||
|
2023
Q2 | $1.94M | Buy |
|
|||||
|
2023
Q1 | $1.29M | Buy |
|
|||||
|
2022
Q4 | $372K | Sell |
|
|||||
|
2022
Q3 | $1.23M | Buy |
|
|||||
|
2022
Q2 | $134K | Sell |
|
|||||
|
2022
Q1 | $306K | Sell |
|
|||||
|
2021
Q4 | $1.43M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $3.51M | Sell |
|
|||||
|
2021
Q1 | $4.22M | Buy |
|
|||||
|
2020
Q4 | $3.73M | Buy |
|
|||||
|
2020
Q3 | $1.05M | Sell |
|
|||||
|
2020
Q2 | $1.24M | Buy |
|
|||||
|
2020
Q1 | $64K | Sell |
|
|||||
|
2019
Q4 | $636K | Buy |
|
|||||
|
2019
Q3 | $321K | Sell |
|
|||||
|
2019
Q2 | $754K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $249K | Buy |
|
|||||
|
2018
Q3 | $333K | Sell |
|
|||||
|
2018
Q2 | $375K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $219K | Buy |
|
|||||
|
2017
Q3 | $67K | Sell |
|
|||||
|
2017
Q2 | $547K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $608K | Buy |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $114K | Buy |
|
|||||
|
2015
Q3 | – | Hold |
|